Navigation Links
Free Download: Two Impressive Case Studies on Drug Delivery Discoveries

SHANGHAI, Sept. 4, 2013 /PRNewswire/ -- Organized by CPhI Conferences, The 3rd NDDS & Clinical Trial Management China 2013, will take place on 27th-28th November at Sheraton HongKou, Shanghai. This year's edition will deliver themes which will drive cross-industry co-operation, highlight the latest market trends, showcase advances in both technique and methodology and provide an effective business networking environment for the conference's participants. The two-day conference will include 3 chapters: Drug discovery and research fulfillments, Novel pathway for future drug delivery solutions and Biotherapeutic drug delivery towards clinical science development. There will be 16 professional presentations and 2 panel discussions, to explore the commercial value, techniques, requirements and clinical science of NDDS. To download the full agenda, please log on to

Meanwhile, the organizer shared two excellent presentations with us about the medical devices industry. The first one was "Oral controlled release dosage form design and case study" by Andy Lu, the General Manager of Shanghai Aucta Pharmaceuticals Co., Ltd. In his speech, he discussed factors for formulation design, formulation and technology selection, formulation evaluation and a few fantastic case studies as well. The second was "Integration of  Nano-and Amorphous Solid Dispersion Formulations into Drug Discovery", by Yaling Wang, the Basic Pharmaceutical Sciences director of Merck Sharp & Dohme Corp. In her speech, she touched on formulation challenges in drug discovery, enhancement of dissolution/solubility limited exposure, nano-suspension formulation and much more. If you are interested in those topics, please CLICK HERE for a free download.

Please click on the following link if the download was unsuccessful:

Media Contact

Ms. Tracy Cui
Tel: +86-21-6157 3919
Fax:+86-21-6157 7299



SOURCE CPhI Conferences
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan Recognizes ResearchDx for Its Impressive Performance in the Companion Diagnostics Sector
2. National Pharmaceutical Council Studies New Formulary Decision-Making Tool
3. Start-up Seeks Crowd Funding to Complete Clinical Studies Supporting Breakthrough Blood Test for Earlier Detection of Melanoma
4. Sihuan Pharmaceutical Secures SFDA Approval for Anaprazole Sodium Category 1.1 New Drug Clinical Studies
5. Phase III studies show linagliptin improved blood glucose control in Asian adults with type 2 diabetes
6. NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinsons Disease
7. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
8. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
9. Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies
10. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
11. ImmunGene and Collaborators Report Positive Results in Pre-clinical Studies of Novel Anti-CD20 Antibody-Interferon Alpha Fusion Protein
Post Your Comments:
(Date:11/30/2015)... TOKYO , Nov. 30, 2015 MEDTEC Japan 2016, ... and Manufacturing industry, is to be held in Tokyo from 20 th  - 22 ... --> -->   --> ...   the United States . With the aging population ... markets continuing to grow steadily. --> the United States ...
(Date:11/30/2015)... 30, 2015  DURECT Corporation (Nasdaq: ... Hogan , Chief Financial Officer, will be ... Tuesday, December 8 at 2:45 pm Eastern ... the Westin Grand Central Hotel in New ... one-on-one meetings at this conference; interested institutional ...
(Date:11/30/2015)... 2015 Next week, December 2-3, BIOMEDevice ... ) co-located events covering the latest in Medtech innovation, ... will draw more than 3,000 design industry professionals to ... The events, combined show floor will host more than ... --> --> BIOMEDevice features suppliers ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates mobile imaging ... owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they are demonstrating ... North America (RSNA) 2015 annual meeting through December 3 in Chicago, Illinois, at ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next IT Healthcare, ... a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program ... as a finalist in the category of Digital Solutions for its innovative, industry-leading ...
(Date:12/1/2015)... ... 01, 2015 , ... Lutronic, a leading innovator of aesthetic and medical laser ... devices for sale in the United States. Clarity is a Superior Dual Wavelength ... lasers, into a single platform that is easy to own and operate. , ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s latest white paper, “ ... a main “pain point” for merging or aligning healthcare provider organizations—when mergers and ... signed. This quick-read guidance suggests that failing to recognize the power of ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... and SACC-USA through membership and leadership since 2008. Gary Bruce, President of ... SACC-USA . Gary has spent a significant amount of time in Sweden since ...
Breaking Medicine News(10 mins):